Literature DB >> 10073780

Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus.

M K Rutter1, J M McComb, S Brady, S M Marshall.   

Abstract

Microalbuminuria is an increase in urinary albumin not detected by conventional dipstick testing and is present in 20% of patients with non-insulin-dependent diabetes mellitus (NIDDM). Mortality in NIDDM patients with microalbuminuria is 60% at 8 years and is mainly due to cardiovascular disease. Because many deaths occur without warning symptoms, we have compared the prevalence and severity of silent myocardial ischemia in asymptomatic NIDDM patients with and without microalbuminuria. We have performed a cross-sectional, case-control study of asymptomatic NIDDM patients attending hospital diabetes clinics. Forty-three patients with microalbuminuria were matched for age, gender, diabetes duration, and smoking status with 43 normoalbuminuric patients. A symptom-limited exercise stress test was performed and reported blind to patient status. The degree of electrocardiographic ST-segment depression, exercise time, work performed, and maximum heart rate with exercise were recorded. Patients with microalbuminuria had a higher prevalence of ischemic response (>1 mm ST depression) (65% vs 40%, p = 0.016), reduced total exercise time (5 vs 7 minutes, p <0.001), reduced work (6 vs 8 METs, p <0.001), and reduced age-predicted maximum heart rate (94% vs 101%, p = 0.004). In multiple logistic regression, albumin excretion rate was shown to be the strongest independent predictor of ischemic response (p = 0.03). Silent myocardial ischemia is common in asymptomatic NIDDM patients but is more common in those with microalbuminuria. In these subjects, the higher prevalence of ischemic response at low workloads suggests a higher probability of future coronary events, and possibly a higher probability of potentially treatable coronary artery disease.

Entities:  

Mesh:

Year:  1999        PMID: 10073780     DOI: 10.1016/s0002-9149(98)00777-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

2.  [Cardiac imaging in (asymptomatic) diabetic patients].

Authors:  M J Zellweger
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

Review 3.  Clinical review: Screening for coronary artery disease in type 2 diabetes.

Authors:  Charles T Upchurch; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

Review 4.  Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.

Authors:  Anum Saeed; Christie M Ballantyne
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

5.  Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Authors:  Anna Grodzinsky; Mikhail Kosiborod; Fengming Tang; Philip G Jones; Darren K McGuire; John A Spertus; John F Beltrame; Jae-Sik Jang; Abhinav Goyal; Neel M Butala; Robert W Yeh; Suzanne V Arnold
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-09

6.  The association of silent coronary artery disease and metabolic syndrome in Chinese with type 2 diabetes mellitus.

Authors:  Jack C-R Tsai; Dao-Ming Chang; Fu-Mei Chung; Jung-Chou Wu; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2004-05-10

7.  Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.

Authors:  Giampiero Giovacchini; Mario Cappagli; Stefano Carro; Sandro Borrini; Antonella Montepagani; Rossella Leoncini; Gianfranco Mazzotta; Gianmario Sambuceti; Giuliano Mariani; Duccio Volterrani; Michael J Zellweger; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

8.  Radial Pulse Spectrum Analysis as Risk Markers to Improve the Risk Stratification of Silent Myocardial Ischemia in Type 2 Diabetic Patients.

Authors:  Chi-Wei Chang; Kuo-Meng Liao; Ying-Chun Chen; Sheng-Hung Wang; Ming-Yie Jan; Gin-Chung Wang
Journal:  IEEE J Transl Eng Health Med       Date:  2018-09-20       Impact factor: 3.316

9.  Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria.

Authors:  Ana Chico; Antoni Tomás; Anna Novials
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

10.  Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Pietro Fratino
Journal:  Cardiovasc Diabetol       Date:  2002-11-22       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.